Quick Poll

Withings Unveils BeamO: A Revolutionary Health Tech Device for At-Home Monitoring

  • Withings BeamO Unveiled: BeamO, priced at R4,748.05, is a 4-in-1 multiscope measuring temperature, EKG, blood oxygen, and functioning as a stethoscope.
  • Comprehensive Health Monitoring: The device integrates advanced technologies for temperature readings, EKG, blood oxygen levels, and innovative stethoscope functionality.
  • Potential Regulatory Hurdles: While Withings targets a June release, FDA clearance delays for EKG and atrial fibrillation detection pose challenges.

In a bold move to revolutionize at-home health monitoring, Withings has unveiled its latest gadget, the BeamO. Priced at R4,748.05, the BeamO is a 4-in-1 multiscope designed to measure temperature, conduct electrocardiograms (EKG), read blood oxygen levels, and function as a stethoscope to monitor heart and lung health.

Comprehensive Health Monitoring in One Device

The Withings BeamO integrates a range of cutting-edge technologies to offer a comprehensive health monitoring solution for families. Let’s take a closer look at its key features:

1. Temperature Measurement

Similar to Withings’ Thermo thermometer, the BeamO allows users to take contactless temperature readings from the temporal artery, providing a quick and convenient way to monitor body temperature.

2. Electrocardiograms (EKG) and Atrial Fibrillation Detection

The device incorporates electrodes for EKG readings, enabling the detection of atrial fibrillation. With a piezoelectric disc, the BeamO captures acoustic noise from the chest or back, converting it into an electric signal for precise EKG measurements.

3. Blood Oxygen Level Readings

Equipped with photoplethysmography (PPG) sensors, the BeamO can measure blood oxygen levels, a crucial metric for assessing respiratory health. This feature is commonly found in smartwatches but is now condensed into a single device.

4. Stethoscope Functionality

One of the most innovative aspects of the BeamO is its incorporation of a piezoelectric disc, allowing it to function as a stethoscope. By capturing acoustic noise from the chest or back, the device provides a novel way to monitor heart and lung health. The audio can be transferred to the Withings app or streamed directly to healthcare providers during telehealth sessions.

5. Data Sharing and Telehealth Integration

The BeamO aims to streamline the health monitoring process by consolidating multiple metrics into one device. Users can save their health data in PDFs for easy sharing with healthcare professionals. Additionally, the stethoscope’s audio can be seamlessly integrated into telehealth sessions, enhancing remote healthcare experiences.

Potential Regulatory Hurdles

While Withings anticipates the BeamO to be available for sale in June, potential challenges lie in the FDA clearance process. Features such as EKG and atrial fibrillation detection require regulatory approval, and delays in this process may impact the device’s release timeline. Withings has had past experiences with CES product announcements and subsequent FDA clearance delays, emphasizing the need for cautious optimism.

In conclusion, the Withings BeamO represents a significant leap in at-home health monitoring, offering a multifunctional device that caters to various health metrics. As the company continues to build its at-home health platform, South African consumers eagerly await the BeamO’s arrival, hopeful that it will bring a new era of accessible and efficient health monitoring to their homes.

Related

Rateweb

South Africa’s primary source of financial tools and information

Contact Us

admin@rateweb.co.za

Disclaimer

Rateweb strives to keep its information accurate and up to date. This information may be different than what you see when you visit a financial institution, service provider or specific product’s site. All financial products, shopping products and services are presented without warranty. When evaluating offers, please review the financial institution’s Terms and Conditions.

Rateweb is not a financial service provider and should in no way be seen as one. In compiling the articles for our website due caution was exercised in an attempt to gather information from reliable and accurate sources. The articles are of a general nature and do not purport to offer specialised and or personalised financial or investment advice. Neither the author, nor the publisher, will accept any responsibility for losses, omissions, errors, fortunes or misfortunes that may be suffered by any person that acts or refrains from acting as a result of these articles.